Refocus Group, Inc.

Equities

RFCS

US75865X2027

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 03:14:35 2024-02-23 pm EST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2017	Refocus Group Submits Final Module for Pre-Market Approval of the VisAbility Micro Insert System for Presbyopia	CI
2017	Refocus Group Concludes 12-Month Follow-Up for Phase 3 Clinical Trial on the Visability(Tm) Micro-Insert System for Presbyopia	CI

Refocus Group Inc. announced that it has received $15 million in funding from WP Global Partners, Inc., MedCare Investment Funds

May 04, 2016

Refocus Group Inc. (OTCPK:RFCS) announced that it has received $15 million in a round of funding on May 5, 2016. The transaction included participation from new investor WP Global Partners, Inc. and returning investors, MedCare Investment Funds and its affiliates. As part of the transaction, Don Phillips from WP Global Partners, Inc. has joined the company’s board of directors.

Latest news about Refocus Group, Inc.

Refocus Group Submits Final Module for Pre-Market Approval of the VisAbility Micro Insert System for Presbyopia	17-12-04	CI
Refocus Group Concludes 12-Month Follow-Up for Phase 3 Clinical Trial on the Visability(Tm) Micro-Insert System for Presbyopia	17-05-04	CI
Refocus Group Inc. announced that it has received $15 million in funding from WP Global Partners, Inc., MedCare Investment Funds	16-05-04	CI
Refocus Group Inc. Announces Executive Changes	13-10-16	CI

Chart Refocus Group, Inc.

Duration

Period

More charts

Company Profile

Refocus Group, Inc. is a medical device company. The Company is involved in researching and developing treatments for human vision disorders, particularly for the treatment of presbyopia. The Companyâs product, VisAbility Micro Insert System, is a binocular presbyopia treatment, which works outside the visual axis. VisAbility Micro Insert System is under clinical trials in the United States and aims to help patients reduce or eliminate their need for reading glasses.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
REFOCUS GROUP, INC.	-.--%	24
MODERNA, INC.	+25.69%	47.9B
LONZA GROUP AG	+46.90%	41.42B
IQVIA HOLDINGS INC.	-3.46%	40.7B
CELLTRION, INC.	-6.20%	28.92B
ICON PUBLIC LIMITED COMPANY	+9.17%	25.55B
ALNYLAM PHARMACEUTICALS, INC.	-20.42%	19.27B
BIO-TECHNE CORPORATION	+0.17%	12.15B
MEDPACE HOLDINGS, INC.	+28.07%	12.14B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.24%	11.99B

Other Biotechnology & Medical Research